CompositionGlizid-M XR 60 Tablet is used to treat type 2 diabetes mellitus, a condition marked by insulin resistance or insufficient insulin production. It combines gliclazide, which stimulates insulin release, with metformin, which decreases liver glucose production and improves insulin sensitivity.
Together, the two components lower blood sugar through complementary actions: gliclazide prompts the pancreas to produce more insulin around meals, while metformin reduces how much glucose the liver releases and helps the body's cells use insulin more effectively.
Take this modified-release tablet as prescribed with a meal, swallowed whole without crushing or chewing, at the same time each day as prescribed. Follow your recommended diet and exercise plan alongside this medicine.
Tell your doctor if you have kidney or liver disease or heart failure, and mention any planned surgery or contrast imaging, as metformin may need to be paused temporarily. Watch for symptoms of low blood sugar, such as sweating or shakiness, and carry a fast-acting sugar source.
